Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokinetics.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples